The Bone Section of the Hellenic Endocrine Society has issued the recommendations herein presented with the aim of providing guidance on optimal management of patients with parathyroid disorders in everyday clinical practice within the Greek health care setting. Although the methodology followed to formulate these recommendations was not strictly based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) principles, they were drawn up after an extensive review of the literature and of the currently available guidelines for the management of parathyroid disorders worldwide. Specifically for primary hyperparathyroidism (PHPT), the 2011 guidelines of the Greek National Organization of Medicines were updated accordingly. In particular, definitions, etiologies, and recommended and optional laboratory and imaging examinations are provided both for PHPT and chronic hypoparathyroidism (HypoPT). Finally, treatment algorithms are provided for the management of both PHPT and HypoPT. Specifically for HypoPT, the treatment algorithm describes the recommended steps that should be followed to achieve optimal management of chronic hypocalcemia and the complications of HypoPT through the conventional treatment available in Greece and the use of recombinant human PTH(1-84).

中文翻译：

---

甲状旁腺疾病的管理：希腊内分泌学会骨科工作组的建议。

希腊内分泌学会骨科已发布本文提出的建议，旨在为希腊医疗保健机构日常临床实践中甲状旁腺疾病患者的最佳管理提供指导。尽管制定这些建议所遵循的方法并非严格基于建议分级评估、制定和评估 (GRADE) 原则，但它们是在对文献和目前可用的甲状旁腺管理指南进行广泛审查后制定的世界范围内的疾病。特别是对于原发性甲状旁腺功能亢进症 (PHPT)，希腊国家药物组织 2011 年的指南进行了相应更新。尤其是定义、病因、为 PHPT 和慢性甲状旁腺功能减退症 (HypoPT) 提供推荐和可选的实验室和影像学检查。最后，提供了用于 PHPT 和 HypoPT 管理的治疗算法。特别是对于 HypoPT，治疗算法描述了应遵循的推荐步骤，以通过希腊可用的常规治疗和使用重组人 PTH(1-84) 实现慢性低钙血症和 HypoPT 并发症的最佳管理。